• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫辛酸治疗口腔黏膜下纤维化(印度疾病)——更美好的明天。

Thioctic acid in oral submucous fibrosis (India's disease) - A better tomorrow.

机构信息

Department of oral medicine and radiology, A. J. Institute of Dental Sciences, Kuntikan, Mangalore, 575004 Karnataka, India.

Department of Pedodontia, A. J. Institute of Dental Sciences, Mangalore, India.

出版信息

J Stomatol Oral Maxillofac Surg. 2018 Apr;119(2):129-134. doi: 10.1016/j.jormas.2017.12.006. Epub 2017 Dec 12.

DOI:10.1016/j.jormas.2017.12.006
PMID:29246754
Abstract

Oral submucous fibrosis (OSMF), because of its common occurrence in Indian population is known as India's disease. Regardless of diagnostic and therapeutic developments, oral potentially malignant disorders (PMD) and cancers are disseminating at a distressing rate. There is this prerequisite for unrelenting determination to find out apt treatment options so that malignant transformation may be prevented and more so the prevailing morbidity and mortality. Considering the frequency with which oral submucous fibrosis undergoes malignant transformation with free radicals playing a major part, the role of antioxidants in general and thioctic acid also known as alpha lipoic acid (ALA) in particular need to be studied in these individuals. Previous few studies indicated the use of alpha lipoic acid in oral submucous fibrosis patients leading to improvement in signs and symptoms. So, it led us to set forth and propose probable role of thioctic acid in improving symptoms in these patients. As oral submucous fibrosis poses as a threat with its various signs and symptoms and as a potentially malignant disorder as well as considering the role of free radicals in malignant transformation, we proposed the possible mechanisms behind the commonest signs and symptoms in oral submucous fibrosis and role of alpha lipoic acid in managing these signs and symptoms.

摘要

口腔黏膜下纤维性变(OSMF)在印度人群中较为常见,因此被称为印度的疾病。尽管在诊断和治疗方面取得了进展,但口腔潜在恶性疾病(PMD)和癌症仍在以令人担忧的速度传播。因此,我们必须坚持不懈地寻找合适的治疗方法,以防止恶性转化,降低目前的发病率和死亡率。考虑到口腔黏膜下纤维性变发生恶性转化的频率很高,自由基起着重要作用,抗氧化剂,特别是硫辛酸(ALA)的作用需要在这些人群中进行研究。以前的一些研究表明,在口腔黏膜下纤维性变患者中使用 ALA 可以改善症状和体征。因此,这促使我们提出并探讨硫辛酸在改善这些患者症状方面的可能作用。由于口腔黏膜下纤维性变具有多种症状和体征,且作为一种潜在的恶性疾病,同时考虑到自由基在恶性转化中的作用,我们提出了口腔黏膜下纤维性变最常见症状背后的可能机制,以及 ALA 在管理这些症状中的作用。

相似文献

1
Thioctic acid in oral submucous fibrosis (India's disease) - A better tomorrow.硫辛酸治疗口腔黏膜下纤维化(印度疾病)——更美好的明天。
J Stomatol Oral Maxillofac Surg. 2018 Apr;119(2):129-134. doi: 10.1016/j.jormas.2017.12.006. Epub 2017 Dec 12.
2
Effectiveness of Aloe Vera and Antioxidant along with Physiotherapy in the Management of Oral Submucous Fibrosis.芦荟、抗氧化剂联合物理治疗在口腔黏膜下纤维化管理中的有效性。
J Contemp Dent Pract. 2016 Jan 1;17(1):78-84. doi: 10.5005/jp-journals-10024-1806.
3
A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: A randomized clinical trial.一项评估番茄红素和姜黄素对口腔黏膜下纤维化患者疗效的比较研究:一项随机临床试验。
Indian J Dent Res. 2018 May-Jun;29(3):303-312. doi: 10.4103/ijdr.IJDR_551_16.
4
Oral submucous fibrosis: An update on pathophysiology of malignant transformation.口腔黏膜下纤维性变:恶性转化的病理生理学更新。
J Oral Pathol Med. 2017 Jul;46(6):413-417. doi: 10.1111/jop.12582. Epub 2017 May 6.
5
An enigmatic pathogenetic mechanism of hypoxia inducible factor - 1/2 alpha in the progression of fibrosis of oral submucous fibrosis and its malignant transformation: A systematic review and meta-analysis.缺氧诱导因子-1/2α在口腔黏膜下纤维性变纤维化及其恶性转化中的神秘发病机制:系统评价和荟萃分析。
Arch Oral Biol. 2024 Jun;162:105944. doi: 10.1016/j.archoralbio.2024.105944. Epub 2024 Mar 5.
6
Potential role of fibroblast senescence in malignant transformation of oral submucous fibrosis.成纤维细胞衰老在口腔黏膜下纤维性变恶性转化中的潜在作用。
Oral Oncol. 2022 Apr;127:105810. doi: 10.1016/j.oraloncology.2022.105810. Epub 2022 Mar 15.
7
Oral submucous fibrosis--a treatment protocol based on clinical study of 100 patients in central India.口腔黏膜下纤维化——基于印度中部100例患者临床研究的治疗方案
Oral Maxillofac Surg. 2015 Jun;19(2):201-7. doi: 10.1007/s10006-014-0478-x. Epub 2014 Dec 17.
8
Estimation of serum beta carotene levels in patients with oral submucous fibrosis in India.印度口腔黏膜下纤维化患者血清β-胡萝卜素水平的评估。
J Oral Sci. 2011 Dec;53(4):427-31. doi: 10.2334/josnusd.53.427.
9
An update on studies on etiological factors, disease progression, and malignant transformation in oral submucous fibrosis.口腔黏膜下纤维化的病因学因素、疾病进展及恶性转化相关研究的最新进展
J Cancer Res Ther. 2017 Jul-Sep;13(3):399-405. doi: 10.4103/0973-1482.179524.
10
Malignant transformation of oral submucous fibrosis in Taiwan: A nationwide population-based retrospective cohort study.台湾口腔黏膜下纤维性变的恶性转化:一项全国性基于人群的回顾性队列研究。
J Oral Pathol Med. 2017 Nov;46(10):1040-1045. doi: 10.1111/jop.12570. Epub 2017 Apr 6.

引用本文的文献

1
Role of micronutrition in patients with oral cancer and nutritional intervention strategies.微量营养素在口腔癌患者中的作用及营养干预策略
Front Nutr. 2025 Jul 24;12:1616344. doi: 10.3389/fnut.2025.1616344. eCollection 2025.
2
Outcome of a Novel Drug Combination in the Medical Management of Oral Submucous Fibrosis Patients: A Retrospective Cohort Study.一种新型药物组合用于口腔黏膜下纤维化患者药物治疗的效果:一项回顾性队列研究
J Maxillofac Oral Surg. 2024 Oct;23(5):1267-1274. doi: 10.1007/s12663-023-02096-y. Epub 2024 Jan 20.